Literature DB >> 12923135

Cumulative delivery rates after ICSI treatment cycles with freshly retrieved testicular sperm: a 7-year follow-up study.

Kaan Osmanagaoglu1, Valerie Vernaeve, Efstratios Kolibianakis, Herman Tournaye, Michel Camus, Andre Van Steirteghem, Paul Devroey.   

Abstract

BACKGROUND: The purpose of this study was to assess cumulative delivery rates in patients with non-obstructive or obstructive azoospermia following treatment by testicular sperm extraction (TESE)-ICSI.
METHODS: A cohort follow-up study was conducted. Between January 1994 and December 2000, 364 couples with obstructive azoospermia underwent a total of 609 fresh TESE-ICSI treatment cycles. In addition, 303 fresh TESE-ICSI treatment cycles were performed in 235 couples for non-obstructive azoospermia. This study included only patients in whom sperm was recovered. In the non-obstructive group, only patients with maturation arrest, atrophic sclerosis and germ cell aplasia were included. The main outcome measure was a delivery beyond 25 weeks gestation.
RESULTS: In patients with obstructive azoospermia, the crude delivery rate after three cycles was 35% while the expected cumulative delivery rate was 48% [95% confidence interval (CI), 41-55]. On the other hand, in patients with non-obstructive azoospermia, the crude cumulative delivery rate after three treatment cycles was 17% while the expected delivery rate was 31% (95% CI, 15-46). A high dropout rate in couples with both non-obstructive and obstructive azoospermia was observed (75 and 50% respectively, after the first cycle).
CONCLUSION: This study shows that there is a value in performing several TESE-ICSI attempts in patients with obstructive and non-obstructive azoospermia. The estimates of the non-obstructive group beginning from the third cycle are less reliable due to fewer patients. However, overall, the obstructive group performed better than the non-obstructive group.

Entities:  

Mesh:

Year:  2003        PMID: 12923135     DOI: 10.1093/humrep/deg346

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

Review 1.  Male factor infertility and ART.

Authors:  Herman Tournaye
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

2.  Embolization of left spermatic vein in non-obstructive azoospermic men with varicocele: role of FSH to predict the appearance of ejaculated spermatozoa after treatment.

Authors:  S D'Andrea; A V Giordano; S Carducci; L Sacchetti; S Necozione; M Costanzo; A De Gregorio; A Micillo; F Francavilla; S Francavilla; A Barbonetti
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

3.  Cryopreservation of testicular and epididymal sperm: techniques and clinical outcomes of assisted conception.

Authors:  Bhushan K Gangrade
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

Review 4.  Reproductive Chances of Men with Azoospermia Due to Spermatogenic Dysfunction.

Authors:  Caroline Kang; Nahid Punjani; Peter N Schlegel
Journal:  J Clin Med       Date:  2021-03-31       Impact factor: 4.241

Review 5.  Severe male factor in in vitro fertilization: definition, prevalence, and treatment. An update.

Authors:  Rossella Mazzilli; Alberto Vaiarelli; Lisa Dovere; Danilo Cimadomo; Nicolò Ubaldi; Susanna Ferrero; Laura Rienzi; Francesco Lombardo; Andrea Lenzi; Herman Tournaye; Filippo Maria Ubaldi
Journal:  Asian J Androl       Date:  2022 Mar-Apr       Impact factor: 3.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.